Roche provides update on FDA Advisory Committee meeting on Columvi combination for ...

Retrieved on: 2025-05-20 19:02:11

Tags for this article:

Click the tags to see associated articles and topics

Roche provides update on FDA Advisory Committee meeting on Columvi combination for .... View article details on hiswai:

Excerpt

n Roche's (RHHBY) Columvi combination therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) demonstrated a 41% reduction in death ...

Article found on: www.gurufocus.com